This page shows the latest MOV-e-AHEAD news and features for those working in and with pharma, biotech and healthcare.
Merck, known as MSD outside the US and Canada, and Ridgeback Biotherapeutics have announced that its MOV-e-AHEAD study has started to enrol its first participants to test antiviral molnupiravir ... It was recently announced that Health Canada will
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.